Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.
作者信息
Olivo Robert E, Scialla Julia J
机构信息
Department of Medicine and.
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
出版信息
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):868-870. doi: 10.2215/CJN.04380417. Epub 2017 May 26.
Abstract
摘要
相似文献
1
Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):868-870. doi: 10.2215/CJN.04380417. Epub 2017 May 26.
2
Phosphate binding and the glyceraldehyde-3-phosphate dehydrogenase reaction.
J Biol Chem. 1953 Aug;203(2):545-62.
3
The binding of diphosphopyridine nucleotide by glyceraldehyde-3-phosphate dehydrogenase.
J Biol Chem. 1953 Aug;203(2):527-44.
4
The binding of inorganic phosphate to myosin in the presence of adenosine triphosphate.
J Biol Chem. 1960 Nov;235:3174-6.
5
Coenzyme binding and the thiol groups of glyceraldehyde-3-phosphate dehydrogenase.
J Biol Chem. 1953 Aug;203(2):563-73.
6
The reactivity of the bound DPN of muscle triose phosphate dehydrogenase.
Biochim Biophys Acta. 1957 Apr;24(1):141-54. doi: 10.1016/0006-3002(57)90157-9.
7
The specific binding of pyridoxal 5'-phosphate to bovine plasma albumin.
J Biol Chem. 1962 Apr;237:1113-20.
8
The binding of diphosphopyridine nucleotide by yeast glyceraldehyde-3-phosphate dehydrogenase.
J Biol Chem. 1959 May;234(5):1286-92.
9
The binding of analogues of diphosphopyridine nucleotide by yeast glyceraldehyde-3-phosphate dehydrogenase.
J Biol Chem. 1959 May;234(5):1293-6.
10
[Trial therapy of malignant bladder tumors by local excision followed by infiltration of radioactive colloidal chromium phosphate].
Acta Urol Belg. 1954 Jun;22(5):318-24.
引用本文的文献
1
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.
Semin Nephrol. 2018 Nov;38(6):542-558. doi: 10.1016/j.semnephrol.2018.08.001.
本文引用的文献
1
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):965-973. doi: 10.2215/CJN.10941016. Epub 2017 May 26.
2
Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.
N Engl J Med. 2016 Nov 3;375(18):1756-1766. doi: 10.1056/NEJMra1510067.
3
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.
Am J Kidney Dis. 2016 Nov;68(5):691-702. doi: 10.1053/j.ajkd.2016.05.015. Epub 2016 Jul 22.
4
Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):232-44. doi: 10.2215/CJN.06800615. Epub 2015 Dec 14.
5
Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis.
J Am Soc Nephrol. 2016 Jul;27(7):2062-8. doi: 10.1681/ASN.2015050546. Epub 2015 Nov 11.
6
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21.
7
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Am J Kidney Dis. 2015 Sep;66(3):479-88. doi: 10.1053/j.ajkd.2015.03.013. Epub 2015 May 7.
8
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
Am J Kidney Dis. 2014 Nov;64(5):770-80. doi: 10.1053/j.ajkd.2014.04.014. Epub 2014 May 13.
9
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
Nat Rev Nephrol. 2014 May;10(5):268-78. doi: 10.1038/nrneph.2014.49. Epub 2014 Apr 1.
10
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
Zotero 插件